Corino Therapeutics

Manufacturing · 1-10 Employees

View Company Info for Free

Overview

Revenue

<$5 Million

Industry

Manufacturing Pharmaceuticals Business Services Research & Development
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1

About Corino Therapeutics

Corino Therapeutics, Inc. is a private, development-stage biopharmaceutical company focused on acquiring, developing, and commercializing innovative products for the treatment of various human diseases, particularly orphan indications. The company is developing CRX-1008, a potent small molecule TTR stabilizer aimed at treating transthyretin amyloidosis (ATTR) and its related conditions. Corino's technologies address significant unmet medical needs and provide improved, cost-effective alternatives to existing treatments. Their target clients include patients suffering from ATTR and healthcare providers seeking novel therapeutic options.Explore more
Popular SearchesCorino Therapeutics IncCorino TherapeuticsSIC Code 28,283NAICS Code 32,325Show more

Corino Therapeutics Org Chart

PhoneEmail
MR

Acting Chief Executive Officer

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.

Is Corino Therapeutics your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Recommended Actions

Compare Similar Companies to Corino Therapeutics

Compare insights from companies similar to Corino Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.

Company Name

Revenue

Number of Employees

Type

Funding

Founded In

Top Executive

Corino Therapeutics

<$5M
1-10
Private
-
2016
<$5M
11-50
Private
$37.9M
2004
TN
Takuma NakatsukaChief Financial Officer
<$5M
11-50
Private
-
1998
TB
Terry BowlinPresident & CEO
<$5M
1-10
Private
-
2007
<$5M
1-10
Private
$25M
2015
MS
Michael StocumPresident & CEO
<$5M
1-10
Private
-
2004
<$5M
1-10
Private
-
2004
N/A
Illustration of an envelope

Company Profile Activity

i

Among all Manufacturing companies

Low Activity

High Activity

Activity Insights

Corino Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.

What does this means?

Corino Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Corino Therapeutics.

Corino Therapeutics Tech Stack

A closer look at the technologies used by Corino Therapeutics

Corino Therapeutics News & Media

Read more news

Top Manufacturing Companies

Frequently Asked Questions Regarding Corino Therapeutics

What is Corino Therapeutics's official website?
Corino Therapeutics's official website is www.corinorx.com
What is Corino Therapeutics's Revenue?
Corino Therapeutics's revenue is <$5 Million
What is Corino Therapeutics's SIC code?
Corino Therapeutics's SIC: 28,283
What is Corino Therapeutics's NAICS code?
Corino Therapeutics's NAICS: 32,325
How many employees does Corino Therapeutics have?
Corino Therapeutics has 1-10 employees
What industry does Corino Therapeutics belong to?
Corino Therapeutics is in the industry of: Manufacturing, Pharmaceuticals, Business Services
What is Corino Therapeutics competition?
Corino Therapeutics top competitors include: Microbiotix, CVI Pharmaceuticals, NapaJen Pharma, Bantam Pharmaceutical
What technology does Corino Therapeutics use?
Some of the popular technologies that Corino Therapeutics uses are: F5 Silverline DDoS Protection, MonsterCommerce, Google Font API, register.com Websites
What does Corino Therapeutics do?

Corino Therapeutics, Inc. is a private, development-stage biopharmaceutical company focused on acquiring, developing, and commercializing innovative products for the treatment of various human diseases, particularly orphan indications. The company is developing CRX-1008, a potent small molecule TTR stabilizer aimed at treating transthyretin amyloid... osis (ATTR) and its related conditions. Corino's technologies address significant unmet medical needs and provide improved, cost-effective alternatives to existing treatments. Their target clients include patients suffering from ATTR and healthcare providers seeking novel therapeutic options.Read More

Is Corino Therapeutics a public company?
Corino Therapeutics is private company therefore does not currently have an official ticker symbol
See more information about Corino Therapeutics

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.